Advertisement

“Wild West” of Molecular Testing? 2

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Caris: A Big Player in Profiling

According to information posted on its website, Caris has profiled the tumors of more than 60,000 cancer patients from 59 countries since 2006; ordered by 6,000 oncologists. The company says it has over 600 employees and operates four laboratories in three metropolitan areas: Dallas, Boston and Phoenix.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).
Advertisement
Advertisement